EP3986897
EGFR INHIBITOR FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.6.2020EP published:
30.8.2023EP application number:
20734871.5
EPO information:
European Patent Register
Max expiry date:
18.6.2040
Title in English:
EGFR INHIBITOR FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
19.6.2020EP application
30.8.2023EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
DOLENTE, CosimoAddress:
4070 Basel, CH
Name:
GOERGLER, AnnickAddress:
4070 Basel, CH
Name:
HEWINGS, DavidAddress:
4070 Basel, CH
Name:
JAESCHKE, GeorgAddress:
4070 Basel, CH
Name:
KUHN, BerndAddress:
4070 Basel, CH
Name:
NAGEL, Yvonne, AliceAddress:
4070 Basel, CH
Name:
OBST SANDER, UlrikeAddress:
4070 Basel, CH
Name:
RICCI, AntonioAddress:
4070 Basel, CH
Name:
RUEHER, DanielAddress:
4070 Basel, CH
Name:
STEINER, SandraAddress:
4070 Basel, CH
Priority
Number:
19181754Date:
21.6.2019Country:
EP
Classification
Categories:
C07D 487/04, A61P 35/00, A61K 31/496, A61K 31/5377, A61K 31/4709, A61K 31/454, A61K 31/4439